Search

Phase change material (PCM) based thermal energy storage (TES) is an important solution to the waste of heat and intermittency of new energy sources. However, the thermal conductivity of most PCMs is low, which severely affects the thermal energy storage performance. Oscillation of the tube bundles in a TES unit can intensify the convection of liquid PCM and, therefore, enhance heat transfer. However, the energy storage performance of bundled-tube TES systems in response to oscillation at different amplitudes and frequencies has not been well understood yet, and the optimum time to apply the oscillation during phase transition remains unexplored. To address this issue, this present study was carried out. First, the melting behaviour of PCM with oscillation starting at different times was investigated. Then, the influences of oscillation frequency and amplitude on the melting performance were explored. Finally, the solidification behaviour of PCM with oscillation starting at different times was examined. Results show that the oscillation can accelerate the phase transition process by enhancing convective heat transfer. Compared to the case without oscillation, the complete melting and solidification times are reduced by 8.2 and 6.7% for the case with oscillation starting at 200 s, respectively. The effect of oscillation frequency on the melting enhancement is negligible, while the oscillation amplitude has an important effect on the melting enhancement. [ABSTRACT FROM AUTHOR]

In an effort to synthesize chemically recyclable thermoplastic elastomers, a redox‐switchable catalytic system was developed to synthesize triblock copolymers containing stiff poly(lactic acid) (PLA) end blocks and a flexible poly(tetrahydrofuran‐co‐cyclohexene oxide) (poly(THF‐co‐CHO) copolymer as the mid‐block. The orthogonal reactivity induced by changing the oxidation state of the iron‐based catalyst enabled the synthesis of the triblock copolymers in a single reaction flask from a mixture of monomers. The triblock copolymers demonstrated improved flexibility compared to poly(l‐lactic acid) (PLLA) and thermomechanical properties that resemble thermoplastic elastomers, including a rubbery plateau in the range of −60 to 40 °C. The triblock copolymers containing a higher percentage of THF versus CHO were more flexible, and a blend of triblock copolymers containing PLLA and poly(d‐lactic acid) (PDLA) end‐blocks resulted in a stereocomplex that further increased polymer flexibility. Besides the low cost of lactide and THF, the sustainability of this new class of triblock copolymers was also supported by their depolymerization, which was achieved by exposing the copolymers sequentially to FeCl3 and ZnCl2/PEG under reactive distillation conditions. [ABSTRACT FROM AUTHOR]

In an effort to synthesize chemically recyclable thermoplastic elastomers, a redox‐switchable catalytic system was developed to synthesize triblock copolymers containing stiff poly(lactic acid) (PLA) end blocks and a flexible poly(tetrahydrofuran‐co‐cyclohexene oxide) (poly(THF‐co‐CHO) copolymer as the mid‐block. The orthogonal reactivity induced by changing the oxidation state of the iron‐based catalyst enabled the synthesis of the triblock copolymers in a single reaction flask from a mixture of monomers. The triblock copolymers demonstrated improved flexibility compared to poly(l‐lactic acid) (PLLA) and thermomechanical properties that resemble thermoplastic elastomers, including a rubbery plateau in the range of −60 to 40 °C. The triblock copolymers containing a higher percentage of THF versus CHO were more flexible, and a blend of triblock copolymers containing PLLA and poly(d‐lactic acid) (PDLA) end‐blocks resulted in a stereocomplex that further increased polymer flexibility. Besides the low cost of lactide and THF, the sustainability of this new class of triblock copolymers was also supported by their depolymerization, which was achieved by exposing the copolymers sequentially to FeCl3 and ZnCl2/PEG under reactive distillation conditions. [ABSTRACT FROM AUTHOR]

Background: Estrogen receptor (ER) positive human epidermal growth factor receptor 2 (HER2) negative breast cancer (ER+/HER2−BC) and triple-negative breast cancer (TNBC) are two distinct breast cancer molecular subtypes, especially in tumor immune microenvironment (TIME). The TIME of TNBC is considered to be more inflammatory than that of ER+/HER2−BC. Natural killer (NK) cells are innate lymphocytes that play an important role of tumor eradication in TME. However, studies focusing on the different cell states of NK cells in breast cancer subtypes are still inadequate. Methods: In this study, single-cell mRNA sequencing (scRNA-seq) and bulk mRNA sequencing data from ER+/HER2−BC and TNBC were analyzed. Key regulator of NK cell suppression in ER+/HER2−BC, S100A9, was quantified by qPCR and ELISA in MCF-7, T47D, MDA-MB-468 and MDA-MB-231 cell lines. The prognosis predictability of S100A9 and NK activation markers was evaluated by Kaplan–Meier analyses using TCGA-BRAC data. The phenotype changes of NK cells in ER+/HER2−BC after overexpressing S100A9 in cancer cells were evaluated by the production levels of IFN-gamma, perforin and granzyme B and cytotoxicity assay. Results: By analyzing scRNA-seq data, we found that multiple genes involved in cellular stress response were upregulated in ER+/HER2−BC compared with TNBC. Moreover, TLR regulation pathway was significantly enriched using differentially expressed genes (DEGs) from comparing the transcriptome data of ER+/HER2−BC and TNBC cancer cells, and NK cell infiltration high/low groups. Among the DEGs, S100A9 was identified as a key regulator. Patients with higher expression levels of S100A9 and NK cell activation markers had better overall survival. Furthermore, we proved that overexpression of S100A9 in ER+/HER2-cells could improve cocultured NK cell function. Conclusion: In conclusion, the study we presented demonstrated that NK cells in ER+/HER2−BC were hypofunctional, and S100A9 was an important regulator of NK cell function in ER+BC. Our work contributes to elucidate the regulatory networks between cancer cells and NK cells and may provide theoretical basis for novel drug development. [ABSTRACT FROM AUTHOR]

Parecoxib, a well‐recognized nonsteroidal anti‐inflammatory drug, has been reported to possess anticancer properties in various tumor types. In this work, we aimed to investigate the potential anticancer effects of parecoxib on hepatocellular carcinoma (HCC) cells. To assess the impact of parecoxib on HCC cell proliferation, we employed Cell Counting Kit‐8, colony formation, and 5‐ethynyl‐2′‐deoxyuridine assays. Hoechst/propidium iodide (PI) double staining and flow cytometry were performed to evaluate apoptosis and cell cycle analysis. Wound healing and transwell assays were utilized to assess cell migration and invasion. Tube formation assay was employed to analyze angiogenesis. Protein levels were determined using western blotting, and mRNA expression levels were assessed using quantitative real‐time polymerase chain reaction (PCR). A xenograft mouse model was used to confirm the antitumor effects of parecoxib on HCC tumors in vivo. Our data demonstrated that parecoxib effectively inhibited the proliferation of HCC cells in a dose‐ and time‐dependent manner. In addition, parecoxib induced cell cycle arrest in the G2 phase and promoted apoptosis. Moreover, parecoxib hindered tumor migration and invasion by impeding the epithelial–mesenchymal transition process. Further investigation showed that parecoxib could significantly suppress angiogenesis through the inhibition of extracellular signal‐regulated kinase (ERK)–vascular endothelial growth factor (VEGF) axis. Notably, treatment with the ERK activator phorbol myristate acetate upregulated the expression of matrix metalloproteinase (MMP)‐2, MMP‐9, and VEGF and reversed the function of parecoxib in HCC cells. Besides, parecoxib displayed its antitumor efficacy in vivo. Collectively, our results suggest that parecoxib ameliorates HCC progression by regulating proliferation, cell cycle, apoptosis, migration, invasion, and angiogenesis through the ERK–VEGF/MMPs signaling pathway. [ABSTRACT FROM AUTHOR]

Acetone-butanol-ethanol (ABE), serving as the intermediate product in the biobutanol production process, has garnered significant attention as a promising alternative fuel, thanks to its ability to avoid the costs and energy consumption associated with biobutanol purification, as well as its potential to improve thermal efficiency and reduce pollutant emissions of internal combustion engine. However, to date, there has been limited in-depth research into the chemical reaction mechanism for the combustion of gasoline-ABE blends and its application in engine simulations. In this study, a skeletal chemical reaction mechanism of gasoline-ABE blends was constructed, which consists of 87 components and 387 reactions, using a manifold trajectory-based dimension reduction algorithm developed by our research group. The findings illustrate that the skeletal mechanism can accurately predict ignition delay, laminar flame speed, and premixed flame species profiles for each component within gasoline-ABE blends, including isooctane, n-heptane, toluene, acetone, butanol, and ethanol. The skeletal mechanism was subsequently coupled with a CFD model to further validate its efficacy in engine combustion simulation. The results indicate that the combustion characteristics of gasoline-ABE blends in the engine can be reliably reproduced. After conducting a comprehensive simulation analysis, it is revealed that gasoline blended with 30 vol% ABE361(A:B:E = 3:6:1) exhibits a shorter initial combustion duration, an extended main combustion duration, reduced CO emissions, but also increased NOx emissions. • The skeletal mechanism of gasoline-ABE blends was constructed using MTDR. • The skeletal mechanism reliably reproduces the combustion characteristics of gasoline-ABE blends. • The addition of 30 vol% ABE361 in gasoline leads to elevated NO and decreased CO emissions. [ABSTRACT FROM AUTHOR]